The adenoma detection rate (ADR) is the primary quality indicator for colonoscopies. The polyp detection rate (PDR) is available from administrative data and does not depend on histology verification. The correlation between PDR and ADR and the ADR/PDR conversion factor in preventive colonoscopies were evaluated. In the prospective study, asymptomatic individuals aged 45-75 years with preventive colonoscopy in 2012-2016 were included. Spearman's correlation coefficient was used to assess PDR/ADR for each endoscopist. Conversion factor predicting ADR from PDR was obtained by linear regression and subsequently compared with adenoma to polyp detection rate quotient. One thousand six hundred fourteen preventive colonoscopies performed by 16 endoscopists in 8 screening colonoscopy centres in the Czech Republic were analysed. Correlation between PDR and ADR in all preventive colonoscopies was high and statistically significant (Rs 0.82; P < 0.001). There was a strong correlation between PDR and ADR in men (Rs 0.74; P = 0.002) and in screening colonoscopies (Rs 0.85; P < 0.001). The conversion factor to convert ADR from PDR was 0.72 in all preventive colonoscopies, 0.76 in FOBT+ colonoscopies and 0.67 in screening colonoscopies. ADR may be replaced by PDR in the assessment of colonoscopy quality. The value of the conversion factor varies according to colonoscopy indication and gender of examined individuals; in this Czech study, it was 0.72 in all preventive colonoscopies. The minimum requested ADR of 25 % corresponds to a PDR of 35 %, when converted with the appropriate conversion factor.

Department of Medicine 1st Faculty of Medicine Charles University Military University Hospital Prague

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

See more in PubMed

Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011; 140:65–72

Binefa G, García M, Milà N, Rodríguez L, Rodríguez-Moranta F, Guardiola J, Moreno V. Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test. Rev Esp Enferm Dig. 2013; 105:400–408

Boroff ES, Gurudu SR, Hentz JG, Leighton JA, Ramirez F. Polyp and adenoma detection rates in the proximal and distal colon. Am J Gastroenterol. 2013; 108:993–999

Bretagne JF, Hamonic S, Piette C, Viel JF, Bouguen G. Interendoscopist variability in proximal colon polyp detection is twice higher for serrated polyps than adenomas. World J Gastroenterol. 2016; 22:8549–8557

Bretthauer M, Kaminski MF, Løberg M, Zauber AG, Regula J, Kuipers EJ, et al.; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016; 176:894–902

Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370:1298–1306

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology. 2012; 142:497–504

Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R. Epidemiology of Malignant Tumours in the Czech Republic [online]. 2007, Czech Republic: Masaryk University

Elhanafi S, Ortiz AM, Yarlagadda A, Tsai C, Eloliby M, Mallawaarachchi I, et al. Estimation of the adenoma detection rate from the polyp detection rate by using a conversion factor in a predominantly hispanic population. J Clin Gastroenterol. 2015; 49:589–593

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49:1374–1403

Ferlitsch M, Heinze G, Salzl P, Britto-Arias M, Waldmann E, Reinhart K, et al. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test. Med Oncol. 2014; 31:151

Francis DL, Rodriguez-Correa DT, Buchner A, Harewood GC, Wallace M. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011; 73:493–497

Gohel TD, Burke CA, Lankaala P, Podugu A, Kiran RP, Thota PN, et al. Polypectomy rate: a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist. Clin Gastroenterol Hepatol. 2014; 12:1137–1142

Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007; 56:210–214

Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff D. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002; 346:1781–1785

Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010; 362:1795–1803

Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, et al. Performance measures for lower gastrointestinal endoscopy: a european society of gastrointestinal endoscopy (ESGE) quality improvement initiative. Endoscopy. 2017; 49:378–397

Marcondes FO, Dean KM, Schoen RE, Leffler DA, Rose S, Morris M, Mehrotra A. The impact of exclusion criteria on a physician’s adenoma detection rate. Gastrointest Endosc. 2015; 82:668–675

Murchie B, Tandon K, Zackria S, Wexner SD, O’Rourke C, Castro F. Can polyp detection rate be used prospectively as a marker of adenoma detection rate? Surg Endosc. 2018; 32:1141–1148

Patel NC, Islam RS, Wu Q, Gurudu SR, Ramirez FC, Crowell MD, Faigel D. Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc. 2013; 77:390–394

Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006; 355:1863–1872

Rembacken B, Hassan C, Riemann JF, Chilton A, Rutter M, Dumonceau JM, et al. Quality in screening colonoscopy: position statement of the european society of gastrointestinal endoscopy (ESGE). Endoscopy. 2012; 44:957–968

Rex DK, Bond JH, Winawer S, Levin TR, Burt RW, Johnson DA, et al.; U.S. Multi-Society Task Force on Colorectal Cancer. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-society task force on colorectal cancer. Am J Gastroenterol. 2002; 97:1296–1308

Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015; 110:72–90

Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017; 152:1217–1237.e3

Schramm C, Scheller I, Franklin J, Demir M, Kuetting F, Nierhoff D, et al. Predicting ADR from PDR and individual adenoma-to-polyp-detection-rate ratio for screening and surveillance colonoscopies: a new approach to quality assessment. United European Gastroenterol J. 2017; 5:742–749

Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016; 22:8103–8111

Suchanek S, Majek O, Vojtechova G, Minarikova P, Rotnaglova B, Seifert B, et al. Colorectal cancer prevention in the czech republic: time trends in performance indicators and current situation after 10 years of screening. Eur J Cancer Prev. 2014; 23:18–26

van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006; 101:343–350

Williams JE, Holub JL, Faigel D. Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc. 2012; 75:576–582

Williams JE, Le TD, Faigel D. Polypectomy rate as a quality measure for colonoscopy. Gastrointest Endosc. 2011; 73:498–506

Wong CK, Fedorak RN, Prosser CI, Stewart ME, van Zanten SV, Sadowski D. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis. 2012; 27:1657–1664

Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, et al. Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol. 2014; 20:3825–3834

Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, et al.; Equipe Working Group. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the equipe study (evaluating quality indicators of the performance of endoscopy). Gut. 2017; 66:1233–1240